Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

NCT00519831 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Drug unavailable

Conditions

Lung Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: vinflunine

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]